Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention

Journal of Invasive Cardiology

Volumn 15, Issue 1, 2003, Pages 18-22

  Iakovou, Ioannis ^a,b   Dangas, George ^a,b   Mehran, Roxana ^a,b   Lansky, Alexandra J ^a,b   Ashby, Dale T ^a,b   Fahy, Martin ^a,b   Mintz, Gary S ^a,b   Kent, Kenneth M ^a,b   Pichard, Augusto D ^a,b   Satler, Lowell F ^a,b   Stone, Gregg W ^a,b   Leon, Martin B ^a,b  

^a CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

Contrast induced nephropathy; Female gender; Percutaneous coronary interventions; Renal failure

Indexed keywords

CONTRAST MEDIUM;

ADULT; AGE DISTRIBUTION; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CHRONIC KIDNEY FAILURE; DIABETES MELLITUS; DISEASE COURSE; FEMALE; FOLLOW UP; GENDER; HEART CATHETERIZATION; HUMAN; HYPERTENSION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; RISK FACTOR; SEX DIFFERENCE; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ATHERECTOMY; CONTRAST MEDIA; CORONARY DISEASE; FEMALE; HUMANS; INCIDENCE; KIDNEY DISEASES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RADIOGRAPHY, INTERVENTIONAL; SEX FACTORS; STENTS;

EID: 0037250407     PISSN: 10423931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. McCullogh PA, Wolyn R, Rocher LL, et al. Acute renal failure after coronary intervention. Incidence, risk factors, and relationship to mortality. Am J Med 1997;103:368-375.
2. Porter GA. Contrast associated nephropathy. Am J Cardiol 1989;64:22E-26E.
3. Gronin RE. Renal failure following radiologic procedures. Am J Med Sci 1989;298:34-356.
4. Gruberg L, Mintz GS, Merhan R, et al. The prognostic implications of further renal functon deterioration within 48 hours of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 2000;36:1542-1548.
5. Smith SC, Dove JT, Jacobs AK, et al. ACC/AHA guidelines for percutaneous coronary intervention: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 2001;37:2239i-1xvi.
6. Pepine CJ, Holmes DR Jr. Coronary artery stents. American College of Cardiology. J Am Coll Cardiol 1996;28:782-794.
7. Mehran R, Dangas G, Mintz GS, et al. Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions: Intravascular ultrasound study of 2256 patients. Circulation 2000;101:604-610.
8. Saucedo JF, Mehran R, Dangas G, et al. Long-term clinical events following creatine kinase-myocardial band isoenzyme elevation after successful coronary stenting. J Am Coll Cardiol 2000;35:1134-1141.
9. Weisberg LS, Kurnid PB, Kurnid BRC. Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. Kidney Int 1994;45:259-265.
10. Rubenstein MH, Harell L, Schunkert H, et al. Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era? Circulation 2000;102:2966-2972.
11. Rubenstein MH, Sheynberg BV, Harell L, et al. Effectiveness of and adverse events after percutaneous coronary intervention in patients with mild versus severe renal failure. Am J Cardiol 2001;87:856-860.
12. Renal Data System. USRDS 1997 annual data report. Bethesda, Md. National Institute of Diabetes and Digestive and Kidney Diseases, April 1997:91-101 (NIH publication no. 97-3176).
13. Cho L, Topol EJ, Bailog C, et al. Clinical benefit of glycoprotein IIb/IIIa blockade with abciximab is independent of gender. J Am Coll Cardiol 2000;36:381-386.
14. Johnson M, Ramey E, Ramwell PW. Sex and age differences in human platelet aggregation. Biochem Soc Transcript 1980;8:180-181.
15. Goldschmidt-Clermont PJ, Schulman SP, Bray PF, et al. Refining the treatment of women with unstable angina-a randomized, double-blind, comparative safety and efficacy evaluation of integrillin vs. aspirin in the management of unstable angina. Clin Cardiol 1996;19:869-874.
16. Okuniewski R, Davis EA, Jarro B, et al. A comparison of the development of renal hypertension in male and female rats. Clin Sci 1998;95:445-451.
17. Gretz N, Zeier M, Geberth S, et al. Is gender a determinant for evolution of renal failure? A study in autosomal dominant polycystic kidney disease. Am J Kidney Dis 1989;14:178-183.
18. Howard BV, Cowan LD, Go O, et al. Adverse effects of diabetes on multiple cardiovascular disease risk factors in women: The Strong Heart Study. Diabetes Care 1998;21:1258-1265.
19. Tsang TSM, Barnes ME, Gersh BJ, et al. Risks of coronary heart disease in women: Current understanding and evolving concepts. Mayo Clin Proc 2000;75:1289-1303.
20. Gerhard M, Roddy MA, Greager SJ, et al. Aging progressively impairs endothelium dependent vasodilation in forearm resistance vessels in humans. Hypertension 1997;30:252-258.
21. Abbate R, Prisco D, Rostango C, et al. Age-related changes in the hemostatic system. Int J Clin Lab Res 1993;23:1-3.